John Evans
Chief Executive Officer and Board Member at Beam Therapeutics
Cambridge, Massachusetts, United States
About
He came to Beam in 2017 from Agios Pharmaceuticals, where he spent eight years as SVP of corporate development and portfolio leadership and served as IDH portfolio executive, and he also worked as a venture partner at ARCH Venture Partners. Earlier in his career he was a director of product development at Infinity Pharmaceuticals and held business analyst and senior associate roles at McKinsey & Company.
Chief Executive Officer and Board Member at Beam Therapeutics
Intro paths
→
In turn, John can intro founders to Beam Therapeutics's investors below.
Beam Therapeutics's investors · 8
ARCH Venture PartnersChicago · $50K – $250M checks · since 2018Dreamers VCEl Segundo · $500K – $5M checks · since 2018Eight Roads VenturesMumbai · $5M – $30M checks · since 2018F-Prime CapitalCambridge · $3M – $10M checks · since 2018Foresite CapitalWest Hollywood · since 2018GV (Google Ventures)Mountain View · $250K – $50M checks · since 2018HongShan Capital GroupHong Kong · $100K – $50M checks · since 2018OUP (Osage University Partners)Bala Cynwyd · $1M – $20M checks · since 2018
Co-founders at Beam Therapeutics
DR
David R. LiuFounder and Inventor
JK
J. Keith JoungFounder and Inventor
FZ
Feng ZhangFounder and Inventor
DR
David R. Liu, Ph.D.Founder and Inventor
JK
J. Keith Joung, M.D., Ph.D.Founder and Inventor
FZ
Feng Zhang, Ph.D.Founder and Inventor
Experience
- Beam TherapeuticsCEOcurrent2017 — presentCambridge, MA
- ARCH Venture PartnersVenture Partner2017 — 2021Cambridge, MA
- Agios PharmaceuticalsSVP, Corporate Development and Portfolio Leadership / IDH Portfolio Executive2009 — 2017
- Infinity PharmaceuticalsDirector, Product Development2006 — 2009
- McKinsey & CompanySenior Associate2005 — 2006
- MedImmuneSummer Associate, Corporate Development2004
- McKinsey & CompanyBusiness Analyst2001 — 2003
Skills & more
Strategy5Biotechnology17Life Sciences5Corporate Development2Business Development10Pharmaceutical Industry8Lifesciences3Product Development7Oncology4Drug Development4
From John's professional profile.
Frequently asked questions
- Who is John Evans?
- He came to Beam in 2017 from Agios Pharmaceuticals, where he spent eight years as SVP of corporate development and portfolio leadership and served as IDH portfolio executive, and he also worked as a venture partner at ARCH Venture Partners. Earlier in his career he was a director of product development at Infinity Pharmaceuticals and held business analyst and senior associate roles at McKinsey & Company.
- Where does John Evans work?
- John Evans is Chief Executive Officer and Board Member at Beam Therapeutics.
- Where did John Evans go to school?
- John Evans studied at The Wharton School (MBA, Healthcare Management); University of Pennsylvania (MA, Biotechnology); Yale University (BA, English).
Same school
Also attended The Wharton School2,000
Sarah GuoFounder & General Partner of ConvictionJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalJack AbrahamFounder, CEO & Managing Partner of AtomicKatie RiesterPartner, Head of Investor Relations at Felicis Ventures
+ 1,994 more
Also attended University of Pennsylvania1,082
Brian ActonCo-founder of WhatsApp; co-founder of Signal FoundationKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalDasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesLeah von SiemensPartner at Manta Ray VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC Partners
+ 1,076 more
Shared employers
Also worked at Beam Therapeutics3
Also worked at ARCH Venture Partners37
Patrick EnnisVenture Partner at Madrona Venture GroupTroy CichosCOO & Partner at Madrona Venture GroupSteve GillisManaging Director at ARCH Venture PartnersClinton BybeeCo-founder & Managing Director, Emeritus at ARCH Venture PartnersJason DorenGeneral Counsel at ARCH Venture PartnersCarol SuhPartner at ARCH Venture Partners
+ 31 more
Also worked at Agios Pharmaceuticals5
Also worked at Infinity Pharmaceuticals11
Paul MeloneInvestor at Third Rock VenturesJeffrey TongPartner at Third Rock VenturesJohn KeiltyVenture Partner at Third Rock VenturesSteve HoltzmanBio Advisor at Amplify PartnersVikas GoyalPartner at Longwood FundAndrew PalmerCo-Founder of Tamr at Underscore VC
+ 5 more